PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

The hitchhiker antigen: Cause for concern?

2013-10-23
(Press-News.org) Contact information: Jenny Ryan
jenny.ryan@nrcresearchpress.com
Canadian Science Publishing (NRC Research Press)
The hitchhiker antigen: Cause for concern? Since antibodies first attained prominence as research reagents in modern biological science labs, researchers have been perplexed as to why one production lot can differ significantly from the next, in terms of performance. Poor antibody performance has caused the loss of countless hours of research, to say nothing of the mental anguish of the researchers themselves. An antigen is a substance that stimulates the production of antibodies.

Now that antibodies are being widely exploited for clinical purposes, the problem of poor antibody performance goes beyond inconvenience to researchers and may threaten patients in a number of ways, including misdiagnosis of disease by pathologists using antibodies to characterize tissue biopsies; disposal of antibody production lots by manufacturers because of the apparent lack of potency; and misinterpretation of research results leading to incorrect conclusions about mechanisms of action for some diseases, which can be costly to pharmaceutical companies pursuing the wrong leads during drug development.

A new article just published in the journal Biochemistry and Cell Biology titled: "Hitchhiker antigens: Inconsistent ChIP results, questionable immunohistology data, and poor antibody performance may have a common factor" describes the problem. It claims that antibodies being manufactured today in large biological systems, whether it is a bioreactor filled with mammalian cells or a living organism, such as a rabbit or a goat, may often have a significant proportion of the lot "contaminated" with the very antigens they are designed to target. The antigens contaminating the antibodies can be thought of as "hitchhikers". This is only a problem if the antibody is designed to target a cellular protein or structure that is already present in the biological system in which it is being made, but such antibodies are increasingly common and are used for research and in medicine.

In this article, the author, Dr. Missag Parseghian, who develops clinical antibodies at Rubicon Biotechnology, introduces readers to a recent survey by the ENCODE consortium of commercial histone-targeting antibodies and how their data highlights the detrimental effects of hitchhiker antigens. His observations may have researchers thinking about the purity of the commercial antibodies sitting in their lab refrigerators. The problem, he says, may be prevalent in a wide array of research areas, not just the areas of chromatin, auto-immune and histone research highlighted here.

"I have been working with antibodies for over 25 years, both as a consumer who uses them in my research and as a scientist working for companies that manufacture them as therapeutics, and what has always struck me about antibodies is the variation in their performance from one lot to the next. Especially when working with antibodies generated from a small research lab and later from a commercial supplier," explained Dr. Parseghian. "Not that one or the other group produces a superior product, rather the same antibody produced by two different groups can show tremendous variation. Understanding and eliminating this variation is critical for successful development of antibody-based biologic agents as drugs."

### The article is published online today in Biochemistry and Cell Biology. Direct link to article: http://www.nrcresearchpress.com/doi/abs/10.1139/bcb-2013-0059


ELSE PRESS RELEASES FROM THIS DATE:

How are Open Access and MOOCS disrupting the academic community in different ways?

2013-10-23
How are Open Access and MOOCS disrupting the academic community in different ways? New article in SAGE Open compares and contrasts the disruptive tensions of open-access publishing with MOOCs Los Angeles, CA (October 23, 2013) Supporters of open academic content ...

New eye treatment effective in laboratory tests

2013-10-23
New eye treatment effective in laboratory tests Promising new approach may lead to treatments for common eye diseases like neovascular macular degeneration and diabetic retinopathy LA JOLLA, CA – October 23, 2013 – A promising technique for treating human eye disease ...

Changes in epigenetic DNA functions reveal how diabetes predisposes individuals to Alzheimer's

2013-10-23
Changes in epigenetic DNA functions reveal how diabetes predisposes individuals to Alzheimer's Mount Sinai researchers hope to exploit findings to develop novel preventive and treatment strategies for Alzheimer's disease New ...

Swiss private banking in clinch with high cost level

2013-10-23
Swiss private banking in clinch with high cost level For the international wealth management industry, 2012 was a more benign year than the harsh 2011. Due to favorable stock and bond markets the volumes of managed funds increased, though not returning to pre-crisis ...

The molecular clock of the common buzzard

2013-10-23
The molecular clock of the common buzzard Bielefeld biologists reveal the influence of genes on dispersal behavior This news release is available in German. Be it hibernation or the routes of migratory birds: all animal behaviour that is subject to annual ...

Nanopore opens new cellular doorway for drug transport

2013-10-23
Nanopore opens new cellular doorway for drug transport A living cell is built with barriers to keep things out – and researchers are constantly trying to find ways to smuggle molecules in.‬ ‪Professor Giovanni Maglia (Biochemistry, Molecular and Structural ...

New software traces origins of genetic disorders 20 times more accurately

2013-10-23
New software traces origins of genetic disorders 20 times more accurately In a bioinformatics breakthrough, iMinds – STADIUS – KU Leuven researchers have successfully applied advanced artificial intelligence to enable the automated analysis of huge amounts of ...

Insights into how TB tricks the immune system could help combat the disease

2013-10-23
Insights into how TB tricks the immune system could help combat the disease Researchers have identified a potential way to manipulate the immune system to improve its ability to fight off tuberculosis (TB). TB is a major problem for both humans and ...

Communication with similar people stronger than believed

2013-10-23
Communication with similar people stronger than believed People's tendency to communicate with similar people is stronger than earlier believed, which restricts the flow of information and ideas in social networks. These are the findings that an Aalto University ...

People don't put a high value on climate protection

2013-10-23
People don't put a high value on climate protection Without further incentives selfish behavior will continue to dominate This news release is available in German. People are bad at getting a grip on collective risks. Climate change is a good ...

LAST 30 PRESS RELEASES:

Recent advances in dynamic biomacromolecular modifications and chemical interventions: Perspective from a Chinese chemical biology consortium

CRF and the Jon DeHaan Foundation to launch TCT AI Lab at TCT 2025

Canada’s fastest academic supercomputer is now online at SFU after $80m upgrades

Architecture’s past holds the key to sustainable future

Laser correction for short-sightedness is safe and effective for older teenagers

About one in five people taking Ozempic, Wegovy or Mounjaro say food tastes saltier or sweeter than before

Taking semaglutide turns down food noise, research suggests

Type 2 diabetes may double risk of sepsis, large community-based study suggests

New quantum sensors can withstand extreme pressure

Tirzepatide more cost-effective than semaglutide in patients with knee osteoarthritis and obesity

GLP-1 drugs shown cost-effective for knee osteoarthritis and obesity

Interactive apps, AI chatbots promote playfulness, reduce privacy concerns

How NIL boosts college football’s competitive balance

Moffitt researchers develop machine learning model to predict urgent care visits for lung cancer patients

Construction secrets of honeybees: Study reveals how bees build hives in tricky spots

Wheat disease losses total $2.9 billion across the United States and Canada between 2018 and 2021

New funding fuels development of first potentially regenerative treatment for multiple sclerosis

NJIT student–faculty team wins best presentation award for ant swarm simulation

Ants defend plants from herbivores but can hinder pollination

When the wireless data runs dry

Inquiry into the history of science shows an early “inherence” bias

Picky eaters endure: Ecologists use DNA to explore diet breadth of wild herbivores

Study suggests most Americans would be healthier without daylight saving time

Increasing the level of the protein PI31 demonstrates neuroprotective effects in mice

Multi-energy X-ray curved surface imaging-with multi-layer in-situ grown scintillators

Metasurface enables compact and high-sensitivity atomic magnetometer

PFAS presence confirmed in the blood of children in Gipuzkoa

Why do people believe lies?

SwRI installs private 5G network for research, development, testing and evaluation

A new perspective in bone metabolism: Targeting the lysosome–iron–mitochondria axis for osteoclast regulation

[Press-News.org] The hitchhiker antigen: Cause for concern?